|
|
Home > Healthcare > Medical > Diagnostics
Testing Laboratories
|
| Published Date:
November 2008
Published By:
First Research, Inc.
Page Count:
10
Order Code:
R3470-1963
|
|
|
|
About 6,000 testing laboratories in the US are in operation, with combined annual revenue of around $9 billion. Major companies include National Technical Systems, and subsidiaries of major corporations such as Pratt & Whitney and Hexagon Metrology. The industry is fragmented: the top 50 firms account for only 35 percent of industry revenue. Most labs have about 10 employees; the largest have more than 1,000.
Testing labs provide a variety of engineering, quality control, and certification services by performing physical and chemical tests on products and processes. Companies perform these tests either in a lab or at the customer’s site. The industry doesn't include medical or pharmaceutical testing.
COMPETITIVE LANDSCAPE
Demand is driven largely by industry and government spending on R&D to improve the efficiency of operations and develop new products and services. The profitability of individual companies depends on technical expertise and the ability to accurately predict project costs. Large labs have advantages in providing a larger breadth of service through multiple locations; some have strategic partnerships with major corporations. Small labs compete effectively by specializing in particular types of service. The industry is labor-intensive: average revenue per worker is less than $100,000. Testing labs compete with internal labs of major corporations and government entities.
PRODUCTS, OPERATIONS & TECHNOLOGY
Major testing lab services include chemical, nondestructive, mechanical, and electrical testing. Chemical testing accounts for about 36 percent of industry revenue; nondestructive testing (testing that doesn't ...
|
Similar Products
• The World Market for Molecular Diagnostics
Published Jan 2009 by Kalorama Information
• Germany In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012
Published Dec 2008 by Global Markets Direct
• Italy In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012
Published Dec 2008 by Global Markets Direct
• Study for Opportunities Assessment for Hepatitis B Therapeutics in Taiwan
Published Dec 2008 by Frost & Sullivan
• Infant Mortality Rate by Country, 2008
Published Dec 2008 by Trimark Publications
• Medical & Imaging Laboratories
Published Dec 2008 by First Research, Inc.
• Israel In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012
Published Dec 2008 by Global Markets Direct
• Republic of Korea In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012
Published Dec 2008 by Global Markets Direct
• Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012
Published Dec 2008 by Global Markets Direct
• Diagnostic substances: Industry Cluster Report
Published Dec 2008 by BizMiner
|
|
|
|
0 items
